Close this search box.


These materials are available for nonprofit educational use. This repository is allowed by copyright disclaimer under title 17, Appendix E, section 107 of the United States Copyright Act. Under this statute, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. As defined, fair use specifically applies to this repository.

Medline Title Search (Dupuytren + transcriptome or gene expression or RNA)

  • Alfonso-Rodríguez C-A, Garzón I, Garrido-Gómez J, et al. Identification of Histological Patterns in Clinically Affected and Unaffected Palm Regions in Dupuytren’s Disease. PLoS One. 2014;9(11):e112457. doi:10.1371/journal.pone.0112457 (PDF)
  • Augoff K, Ratajczak K, Gosk J, Tabola R, Rutowski R. Gelatinase A activity in Dupuytren’s disease. J Hand Surg Am. 2006;31(10):1635-1639. doi:10.1016/j.jhsa.2006.08.007 (PDF)
  • Becker K, Tinschert S, Lienert A, et al. The importance of genetic susceptibility in Dupuytren’s disease. Clin Genet. 2014;87(5):483-487. doi:10.1111/cge.12410 (PDF)
  • Becker K, Siegert S, Toliat MR, et al. Meta-Analysis of Genome-Wide Association Studies and Network Analysis-Based Integration with Gene Expression Data Identify New Suggestive Loci and Unravel a Wnt-Centric Network Associated with Dupuytren’s Disease. PLoS One. 2016;11(7):e0158101. doi:10.1371/journal.pone.0158101 (PDF)
  • Becker K, Du J, Nürnberg P, Hennies HC. Network Analysis and Fine- Mapping GWAS Loci to Identify Genes and Functional Variants Involved in the Development of Dupuytren Disease. In: Werker P, Dias J, Eaton C, Reichert B, Wach W, eds. Dupuytren Disease and Related Diseases – The Cutting Edge. Springer; 2017:105-111. doi:10.1007/978-3-319-32199-8 (PDF)
  • Bujak M, Ratkaj I, Markova-Car E, et al. Inflammatory Gene Expression Upon TGF-β1-Induced p38 Activation in Primary Dupuytren’s Disease Fibroblasts. Front Mol Biosci. 2015;2(December):68. doi:10.3389/fmolb.2015.00068 (PDF)
  • Dolmans GH, Werker PM, Hennies HC, et al. Wnt signaling and Dupuytren’s disease. N Engl J Med. 2011;365(4):307-317. doi:10.1056/NEJMoa1101029 (PDF)
  • Forrester HB, Temple-Smith P, Ham S, de Kretser D, Southwick G, Sprung CN. Genome-wide analysis using exon arrays demonstrates an important role for expression of extra-cellular matrix, fibrotic control and tissue remodelling genes in Dupuytren’s disease. PLoS One. 2013;8(3):e59056. doi:10.1371/journal.pone.0059056 (PDF)
  • Hindocha S. Identification of biomarkers and whole genome scanning in Dupuytren’s Disease. A thesis submitted to the University of Manchester for the degree of Doctor ofMedicine in the Faculty of Medical & Human Sciences. pp 1-342; 2013. (PDF)
  • Jung J, Kim GW, Lee B, Joo JWJ, Jang W. Integrative genomic and transcriptomic analysis of genetic markers in Dupuytren ’ s disease. 2019;12(Suppl 5):1-10. (PDF)
  • Jupp O, Pullinger M, Marjoram T, Lott M, Chojnowski AJ, Clark IM. Biomarkers of Postsurgical Outcome in Dupuytren Disease. In: Werker P, Dias J, Eaton C, Reichert B, Wach W, eds. Dupuytren Disease and Related Diseases – The Cutting Edge. Springer; 2017:55-61. doi:10.1007/978-3-319-32199-8 (PDF)
  • Kabbabe B, Ramkumar S, Richardson M. Cytogenetic analysis of the pathology of frozen shoulder. Int J Shoulder Surg. 2010;4(3):75. doi:10.4103/0973-6042.76966 (PDF)
  • Karkampouna S, Kloen P, Obdeijn MC, Riester SM, van Wijnen AJ, Kruithof-de Julio M. Human Dupuytren’s Ex Vivo Culture for the Study of Myofibroblasts and Extracellular Matrix Interactions. J Vis Exp. 2015;(98):1-9. doi:10.3791/52534 (PDF)
  • Karkampouna S, Kreulen M, Obdeijn MC, et al. Connective Tissue Degeneration: Mechanisms of Palmar Fascia Degeneration (Dupuytren’s Disease). Curr Mol Biol Reports. 2016:133-140. doi:10.1007/s40610-016-0045-3 (PDF)
  • Kuhn MA, Payne WG, Kierney PC, et al. Cytokine manipulation of explanted Dupuytren’s affected human palmar fascia. Int J Surg Investig. 2001;2(6):443-456. Accessed October 17, 2013. (PDF)
  • Kuhn MA, Wang X, Payne WG, Ko F, Robson MC. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren’s affected palmar fascia . J Surg Res . 2002;103(2):52-146. doi:10.1006/jsre.2001.6350 (PDF)
  • Larsen S, Krogsgaard DG, Aagaard Larsen L, Iachina M, Skytthe A, Frederiksen H. Genetic and environmental influences in Dupuytren’s disease: a study of 30,330 Danish twin pairs. J Hand Surg Eur Vol. 2015;40(2):171-176. doi:10.1177/1753193414535720 (PDF)
  • Major M, Freund MK, Burch KS, et al. Integrative analysis of Dupuytren’s disease identifies novel risk locus and reveals a shared genetic etiology with BMI. Genet Epidemiol. 2019;(January):gepi.22209. doi:10.1002/GEPI.22209 (PDF)
  • Mosakhani N, Guled M, Lahti L, et al. Unique microRNA profile in Dupuytren’s contracture supports deregulation of Β-catenin pathway. Mod Pathol. 2010;23(11):1544-1552. doi:10.1038/modpathol.2010.146 (PDF)
  • Mayerl C, Del Frari B, Parson W, et al. Characterisation of the inflammatory response in Dupuytren’s disease. J Plast Surg Hand Surg. 2016;6764(February):1-9. doi:10.3109/2000656X.2016.1140054 (PDF)
  • Ng M, Thakkar D, Southam L, et al. A Genome-wide Association Study of Dupuytren Disease Reveals 17 Additional Variants Implicated in Fibrosis. Am J Hum Genet. 2017;101(3):417-427. doi:10.1016/j.ajhg.2017.08.006 (PDF)
  • O’Gorman DBO. The Extracellular Matrix in Dupuytren Disease. In: Werker P, Dias J, Eaton C, Reichert B, Wach W, (Eds.), Dupuytren Disease and Related Diseases – The Cutting Edge, DOI 10.1007/978-3-319-32199-8_6. ; 2017:43-54. doi:10.1007/978-3-319-32199-8 (PDF)
  • Ratajczak-Wielgomas K, Gosk J, Rabczyński J, et al. Expression of MMP-2, TIMP-2, TGF-β1, and decorin in Dupuytren’s contracture. Connect Tissue Res. 2012;53(6):469-477. doi:10.3109/03008207.2012.686542 (PDF)
  • Ratkaj I, Bujak M, Jurišić D, et al. Microarray analysis of Dupuytren’s disease cells: the profibrogenic role of the TGF-β inducible p38 MAPK pathway. Cell Physiol Biochem. 2012;30(4):927-942. doi:10.1159/000341470 (PDF)
  • Raykha C, Crawford J, Gan BS, Fu P, Bach LA, O’Gorman DB. IGF-II and IGFBP-6 regulate cellular contractility and proliferation in Dupuytren’s disease. Biochim Biophys Acta. 2013;1832(10):1511-1519. doi:10.1016/j.bbadis.2013.04.018 (PDF)
  • Rehman S, Day PJR, Bayat A, Westerhoff H V. Understanding Dupuytren’s disease using systems biology: A move away from reductionism. Front Physiol. 2012;3 AUG:316. doi:10.3389/fphys.2012.00316 (PDF)
  • Rehman S, Goodacre R, Day PJ, Bayat A, Westerhoff H V. Dupuytren’s: a systems biology disease. Arthritis Res Ther. 2011;13(5):238. doi:ar3438 [pii]\r10.1186/ar3438 (PDF)
  • Rehman S, Salway F, Stanley JK, Ollier WER, Day P, Bayat A. Molecular phenotypic descriptors of Dupuytren’s disease defined using informatics analysis of the transcriptome. J Hand Surg Am. 2008;33(3):359-372. doi:10.1016/j.jhsa.2007.11.010 (PDF)
  • Rehman S, Xu Y, Dunn WB, et al. Dupuytren’s disease metabolite analyses reveals alterations following initial short-term fibroblast culturing. Mol Biosyst. 2012;8(9):2274-2288. doi:10.1039/c2mb25173f (PDF)
  • Rehman S. A Systems Approach to Understanding Dupuytren’s Disease A thesis submitted to The University of Manchester for the degree of Doctor of Philosophy in the Faculty of Engineering and Physical Sciences. 2011. (PDF)
  • Riester SM, Arsoy D, Camilleri ET, et al. RNA sequencing reveals a depletion of collagen targeting microRNAs in Dupuytren’s disease. BMC Med Genomics. 2015;8(1):59. doi:10.1186/s12920-015-0135-8 (PDF)
  • Satish L, LaFramboise WA, O’Gorman DB, et al. Identification of differentially expressed genes in fibroblasts derived from patients with Dupuytren’s Contracture . BMC Med Genomics. 2008;1:10. doi:10.1186/1755-8794-1-10 (PDF)
  • Satish L, Gallo PH, Baratz ME, Johnson S, Kathju S. Reversal of TGF-beta1 stimulation of alpha-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren’s-derived fibroblasts . BMC Musculoskelet Disord . 2011;12:113. doi:10.1186/1471-2474-12-113 (PDF)
  • Satish L, LaFramboise WA, Johnson S, et al. Fibroblasts from phenotypically normal palmar fascia exhibit molecular profiles highly similar to fibroblasts from active disease in Dupuytren’s Contracture. BMC Med Genomics. 2012;5:15. doi:10.1186/1755-8794-5-15 (PDF)
  • Satish L, O’Gorman DB, Johnson S, et al. Increased CCT-eta expression is a marker of latent and active disease and a modulator of fibroblast contractility in Dupuytren’s contracture . Cell Stress Chaperones. 2013;18(4):397-404. doi:10.1007/s12192-012-0392-9 (PDF)
  • Satish L, Palmer B, Liu F, et al. Developing an animal model of Dupuytren’s disease by orthotopic transplantation of human fibroblasts into athymic rat. BMC Musculoskelet Disord. 2015;16(1):138. doi:10.1186/s12891-015-0597-z (PDF)
  • Sayadi LR, Alhunayan D, Sarantopoulos N, et al. The Molecular Pathogenesis of Dupuytren Disease. Ann Plast Surg. 2019;00(00):1. doi:10.1097/sap.0000000000001918 (PDF)
  • Sedic M, Pavelic SK, Hock K. Using functional genomics to identify drug targets: a Dupuytren’s disease example. Methods Mol Biol. 2012;910:15-31. doi:10.1007/978-1-61779-965-5_2 (PDF)
  • Shih B, Brown JJ, Armstrong DJ, Lindau T, Bayat A. Differential gene expression analysis of subcutaneous fat, fascia, and skin overlying a dupuytren’s disease nodule in comparison to control tissue. Hand. 2009;4(3):294-301. doi:10.1007/s11552-009-9164-0 (PDF)
  • Shih B, Watson S, Bayat A. Whole genome and global expression profiling of Dupuytren’s disease: systematic review of current findings and future perspectives. Ann Rheum Dis. 2012;71(9):147-1440. doi:10.1136/annrheumdis-2012-201295 (PDF)
  • Shih B, Wijeratne D, Armstrong DJ, Lindau T, Day P, Bayat A. Identification of biomarkers in Dupuytren’s disease by comparative analysis of fibroblasts versus tissue biopsies in disease-specific phenotypes. J Hand Surg Am. 2009;34(1):124-136. doi:10.1016/j.jhsa.2008.09.017 (PDF)
  • Vi L, Feng L, Zhu RD, et al. Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren’s disease and adjacent palmar fascia cells. Exp Cell Res. 2009;315(20):3574-3586. doi:10.1016/j.yexcr.2009.07.015 (PDF)
  • Vi L, Njarlangattil A, Wu Y, Gan BS, O’Gorman DB. Type-1 Collagen differentially alters beta-catenin accumulation in primary Dupuytren’s Disease cord and adjacent palmar fascia cells. BMC Musculoskelet Disord. 2009;10:72. doi:10.1186/1471-2474-10-72 (PDF)